Vasopressors or Fluids in Early Septic Shock.

Early vasopressor therapy with restricted fluids in septic shock does not improve 90-day survival or hospital discharge days compared to larger fluid volumes with delayed vasopressors in 963 patients.

• Why it matters: Determining the optimal early resuscitation strategy in septic shock is crucial to improve patient outcomes and minimize potential harm from excessive fluid administration.
• What they did: A randomized trial assigned 963 adult septic shock patients to either early vasopressors with limited fluids or larger fluid volumes with delayed vasopressors, monitoring days alive and out of hospital over 90 days.
• The result: Both groups had a median of 76 days alive and out of hospital at day 90, with similar adverse events except for less pulmonary edema in the vasopressor group, indicating no clear benefit of early vasopressors over fluids alone.